EXICORT
ItalyIt is used to treat the symptoms of hay fever (seasonal allergic rhinitis) and perennial rhinitis in adults and children from 3 years of age and older. In adults aged 18 and over, it is also indicated for the treatment of nasal polyps.
Frequently asked questions
How should EXICORT be taken?
The medicine should be used following a doctor's instructions. For hay fever and perennial rhinitis, the dose for adults and children over 12 years of age is 2 sprays per nostril once daily. For children aged 3 to 11 years, the dose is 1 spray per nostril once daily. For nasal polyps in adults, the initial dose is 2 sprays per nostril once daily.
When should you not use this medicine?
It must not be used if you are allergic to mometasone furoate or any of the other ingredients, if you have an untreated nasal infection (such as herpes), or if you have recently undergone nasal surgery or trauma. It is necessary to wait for the infection or trauma to heal before starting use.
What are the side effects of EXICORT?
Common side effects may include headache, sneezing, nasal burning, nosebleeds, nose or throat pain, nasal ulcers, and respiratory tract infections. Changes in taste and smell, blurred vision, or breathing difficulties may also occur. In case of severe allergic reactions (swelling of the face, tongue, or difficulty breathing), stop use immediately and consult a doctor.
Are there any special precautions for children?
Yes, the use of high-dose corticosteroid nasal sprays for long periods can cause growth retardation in children. It is recommended to regularly monitor their height during treatment.
Can I take other medicines with this spray?
It is important to inform your doctor if you are taking other medicines, especially other corticosteroids (oral or injectable) or medicines for the treatment of HIV (such as ritonavir or cobicistat), as they may interact with the treatment.
Instructions for use
PACKAGE LEAFLET
Package leaflet: Information for the user
EXICORT 50 micrograms/dose Nasal Spray, Suspension
Mometasone Furoate
Generic medicine
Please read this leaflet carefully before using this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not give it to others, even if their symptoms are the same as yours, as it may be harmful.
- If any side effect occurs, including those not listed in this leaflet, consult your doctor or pharmacist. See section 4.
Contents of this leaflet
- What EXICORT is and what it is used for
- What you need to know before using EXICORT
- How to use EXICORT
- Possible side effects
- How to store EXICORT
- Contents of the pack and other information
1. What EXICORT is and what it is used for
What is EXICORT?
EXICORT nasal spray contains mometasone furoate, which belongs to a group of medicines known as corticosteroids. Mometasone furoate should not be confused with "anabolic" steroids, substances improperly used by some athletes and taken intravenously or in tablet form. When mometasone furoate is sprayed into the nose, it can help relieve inflammation (swelling and irritation of the nose), sneezing, itching, nasal congestion, or a runny nose.
What is EXICORT used for?
Hay fever and perennial rhinitis
EXICORT is used to treat symptoms of hay fever (also known as seasonal allergic rhinitis) and perennial rhinitis in adults and children aged 3 years and older. Hay fever occurring at certain times of the year is an allergic reaction caused by inhaling tree, grass, and weed pollens, as well as moulds and fungal spores. Perennial rhinitis is present throughout the year, and symptoms may be triggered by sensitivity to various allergens, including house dust mites, animal fur (or dander), feathers, and certain foods. EXICORT reduces swelling and irritation in the nasal passages, thereby relieving sneezing, itching, and nasal congestion or runny nose caused by hay fever or perennial rhinitis.
Nasal polyps
EXICORT is used to treat nasal polyps in adults aged 18 years and older. Nasal polyps are small growths on the nasal mucosa and usually affect both nostrils. EXICORT reduces inflammation in the nose, leading to a gradual shrinkage of the polyps, thereby relieving nasal obstruction and improving nasal breathing.
2. What you need to know before using EXICORT
Do not use EXICORT
- if you are allergic to mometasone furoate or to any of the other ingredients of this medicine (listed in section 6).
- if you have an untreated nasal infection. Using EXICORT during an untreated nasal infection, such as herpes, may worsen the infection. You should wait until the infection has resolved before starting to use the nasal spray.
- if you have recently undergone nasal surgery or have suffered a nasal injury. You must not use the nasal spray until your nose has healed.
Warnings and precautions
Talk to your doctor or pharmacist before using EXICORT:
- if you have or have had tuberculosis.
- if you have any other type of infection.
- if you are taking other corticosteroid medicines, either by mouth or by injection.
- if you have cystic fibrosis.
During treatment with EXICORT, contact your doctor:
- if your immune system is not working properly (difficulty fighting infections) and you are exposed to people with measles or chickenpox. Avoid contact with people who have these infections.
- if you develop a nasal or throat infection.
- if you have been using this medicine for several months or longer.
- if you experience persistent irritation of the nose or throat.
When corticosteroid nasal sprays are used at high doses for prolonged periods, adverse effects due to systemic absorption of the medicine may occur.
If you experience eye itching or irritation, your doctor may prescribe additional treatments to use alongside EXICORT Nasal Spray.
Contact your doctor if you develop blurred vision or any other visual disturbances.
Children
When corticosteroid nasal sprays are used at high doses and for prolonged periods, they may cause adverse effects, such as growth retardation in children.
Regular monitoring of height is recommended in children undergoing long-term treatment with nasal corticosteroids. If you notice any changes, inform your doctor.
Other medicines and EXICORT
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
If you are taking other corticosteroid medicines for allergy treatment, either orally or by injection, your doctor may advise you to discontinue such treatment when starting EXICORT. After stopping oral or injectable corticosteroids, some people may experience adverse effects such as joint or muscle pain, weakness, and depression. You may also feel as though you are developing other allergies, such as itching, tearing, or red, itchy skin rashes.
Contact your doctor if you experience any of these effects.
Some medicines may increase the effects of EXICORT, and your doctor may wish to monitor you closely if you are taking these medicines (including certain HIV treatments: ritonavir, cobicistat).
Pregnancy, breastfeeding and fertility
Information on the use of mometasone furoate in pregnant women is limited or lacking. It is not known whether mometasone furoate passes into breast milk.
If you are pregnant, suspect you may be pregnant, planning a pregnancy, or breastfeeding, consult your doctor or pharmacist before taking this medicine.
Driving and using machines
No information is available on the effects of mometasone furoate on the ability to drive vehicles or operate machinery.
EXICORT contains benzalkonium chloride
This medicine contains 20 micrograms of benzalkonium chloride per dose, which may cause irritation or swelling inside the nose, especially if used for a prolonged period.
3. How to use EXICORT
Use this medicine exactly as directed by your doctor. If you have any doubts, consult your doctor or pharmacist. Do not use a higher dose, or use the spray more frequently or for longer than prescribed by your doctor.
Treatment of hay fever and perennial rhinitis
Use in adults and children over 12 years of age
The recommended dose is 2 sprays into each nostril once daily.
In some patients, EXICORT Nasal Spray begins to relieve symptoms within 12 hours of the first dose. However, it may take more than two days to achieve the full benefit of treatment. Therefore, it is necessary to continue using it regularly to fully benefit from its effectiveness.
- Once symptoms are under control, your doctor may advise you to reduce the dose to one spray once daily in each nostril.
- If you do not notice any improvement, consult your doctor, who may prescribe an increase in dose; the maximum daily dose is 4 sprays into each nostril once daily.
Use in children aged 3 to 11 years
The recommended dose is 1 spray into each nostril once daily.
If you or your child suffers from severe hay fever, your doctor may advise you to start using EXICORT several days before the expected start of pollen season: this will help prevent the onset of hay fever symptoms. At the end of the pollen season, hay fever symptoms may subside, making treatment unnecessary.
Nasal polyps
Use in adults over 18 years of age
The recommended initial dose is 2 sprays into each nostril once daily.
- If symptoms are not controlled after 5 or 6 weeks, the dose may be increased to 2 sprays into each nostril twice daily. Once symptoms are under control, your doctor may advise you to reduce the dose.
- If no improvement is observed after 5 to 6 weeks of twice-daily administration, contact your doctor to discuss alternative treatments instead of EXICORT Nasal Spray.
How to prepare the nasal spray for use
EXICORT Nasal Spray is equipped with a dust cap that protects the nozzle and keeps it clean. Remember to remove the cap before using the spray and replace it after use.
If you are using the spray for the first time, you must prime the pump 10 times until you see a fine, uniform mist:
- Gently shake the bottle.
- Place your index and middle fingers on either side of the nozzle, and your thumb under the base of the bottle. Do not pierce the nasal applicator.
- To prime the spray, point the nozzle away from yourself and press down 10 times with your fingers until a uniform spray is produced. If you have not used the spray for 14 days or more, you must re-prime the pump by pressing it 2 times until you see a uniform mist.
Duration of the nasal spray
With two sprays into each nostril once daily, the product should provide sufficient dose for 15 days (for the bottle containing 60 metered sprays) and 35 days (for the bottle containing 140 metered sprays).
How to use the nasal spray
- Gently shake the bottle and remove the dust cap. (Figure 1)
- Gently blow your nose.
- Close one nostril and insert the nozzle into the other as shown (Figure 2).
Tilt your head slightly forward, keeping the bottle upright.
- Begin to inhale gently or slowly through your nose and administer one spray into the nostril by pressing ONCE with your fingers.
- Breathe out through your mouth. Repeat step 4 to inhale a second spray into the same nostril, if required.
- Remove the nozzle from the nostril and breathe out through your mouth.
- Repeat steps 3 to 6 for the other nostril (Figure 3). After using the product, clean the nozzle thoroughly with a tissue or clean cloth and replace the dust cap.
How to clean the nasal spray
- It is important to clean the nasal spray regularly; otherwise, it may not work properly.
- Remove the dust cap and gently remove the nozzle.
- Wash the nozzle and dust cap with lukewarm water, then rinse under running water.
- Do not attempt to unblock the nasal applicator by inserting a pin or any other sharp object, as this may damage the applicator and prevent delivery of the correct dose of medicine.
- Allow the dust cap and nozzle to dry in a warm place.
- Reattach the nozzle to the bottle and replace the dust cap.
- After cleaning, the spray must be re-primed with at least 2 sprays before first use.
If you use more EXICORT than you should
Inform your doctor if you have accidentally used more than the prescribed dose.
In rare cases, prolonged use or high doses of steroids may affect levels of certain hormones. In children, this effect may influence growth and development.
If you forget to take EXICORT
If you forget to take EXICORT nasal spray at the usual time, take it as soon as you remember, then continue your treatment as usual. Do not use a double dose to make up for the missed dose.
If you stop using EXICORT
In some patients, symptoms begin to improve within 12 hours after the first dose of EXICORT Nasal Spray. However, full therapeutic benefit may not be apparent until after two days. It is very important that you use the nasal spray regularly. Do not stop treatment, even if you feel better, unless instructed to do so by your doctor.
If you have any doubts about how to use this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everyone experiences them.
Immediate allergic (hypersensitivity) reactions may occur with the use of this medicine.
These reactions can be severe. You must stop taking EXICORT and seek immediate medical attention if any of the following symptoms occur:
- swelling of the face, tongue or throat
- difficulty swallowing
- hives
- shortness of breath or breathing difficulties
When corticosteroid nasal sprays are used at high doses for long periods of time, side effects due to systemic absorption of the medicine may occur.
Other side effects
Most people do not experience problems when using the nasal spray. However, some people, after using EXICORT and other corticosteroid nasal sprays, may experience:
Common side effects (may affect up to 1 in 10 people):
- headache
- sneezing and nasal irritation/burning sensation
- nosebleeds (epistaxis) [reported very commonly (may affect more than 1 in 10 people) in patients with nasal polyps treated with EXICORT two sprays in each nostril twice daily]
- nasal or throat pain
- nasal ulcers
- respiratory tract infection
Not known (frequency cannot be estimated from the available data):
- increased pressure inside the eye (glaucoma) and/or cataracts causing vision disturbances
- damage to the nasal septum separating the nostrils
- changes in taste and smell
- difficulty breathing and/or breathlessness
- blurred vision
Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system at: http://www.agenziafarmaco.gov.it/content/come-segnalare-una-sospetta-reazione-avversa.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store EXICORT
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the vial and carton after “Exp.”.
The expiry date refers to the last day of that month.
Do not store above 25°C. Do not freeze.
The vial should be used within 8 weeks of first use.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Package contents and other information
What EXICORT contains
- The active substance is mometasone furoate. Each spray (0.1 ml) contains 50 micrograms of mometasone furoate (as monohydrate). The total weight of one spray is 100 mg.
- The other components are microcrystalline cellulose and sodium carmellose, glycerol, sodium citrate dihydrate, citric acid monohydrate, polysorbate 80, benzalkonium chloride (see section 2), and water for injections.
Description of the appearance of EXICORT and contents of the pack
EXICORT is a nasal spray suspension.
Each bottle contains: 60 sprays or 140 sprays.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Exipharma SRL
via del Giglio 40/A,
35133 - Padova (PD)
Manufacturer
Teva Czech Industries s.r.o.
Ostravská 29, č.p. 305, 747 70 Opava, Komárov
Czech Republic
This medicinal product is authorised in the European Economic Area Member States under the
following names:
Italy: EXICORT
Similar drugs
| Brand name | Dosage form | Active substance / Dosage | Manufacturer |
|---|---|---|---|
| ARINIT | spray, nasal suspension | D.M.G. ITALIA S.R.L. | |
| BREXCORT | spray, nasal suspension | DYMALIFE PHARMACEUTICAL S.R.L. | |
| BRUSONEX | spray, nasal suspension | BRUSCHETTINI S.R.L. | |
| CALIMIX | spray, nasal suspension | LABORATORIO CHIMICO DECA DR.CAPUANI S.R.L. | |
| EMMARIN | spray, nasal suspension | FARMA GROUP S.R.L. | |
| METACORT | spray, nasal suspension | S.F. GROUP S.R.L. | |
| MOMECORT | spray, nasal suspension | FARTO S.R.L. - FARMACO BIOCHIMICO TOSCANO | |
| MOMETASONE EG | spray, nasal suspension | EG S.P.A. | |
| MOMETASONE TEVA | spray, nasal suspension | TEVA ITALIA S.R.L. | |
| MOMETASONE ZENTIVA | spray, nasal suspension | ZENTIVA ITALIA S.R.L. | |
| MOMIL | spray, nasal suspension | LABORATORIO CHIMICO DECA DR.CAPUANI S.R.L. | |
| NASONEX | spray, nasal suspension | ORGANON ITALIA S.R.L. |
The original data is available in the language of the country of manufacture.
Data source: Italian Medicines Agency (AIFA)
Data last verified: September 21, 2026